Provided herein are methods for making foam materials and foam material products having a polyurethane foam matrix defining a plurality of pores, a hydrophilic agent retained within at least a portion of the pores for improving an absorption of the foam material, a salt retained within at least a portion of the pores in an amount sufficient to render the foam material isotonic, a surfactant retained within at least a portion of the pores in an amount sufficient to be released upon contact with a moist surface. Also provided herein are methods for making a multilayer foam by casting a second foam layer on a first foam layer substrate and compressing the second foam layer before the second layer is fully cured to form an interface layer in situ.

An absorbent article and method of making the absorbent article are disclosed. The absorbent article having a topsheet, a backsheet, and an absorbent core structure having one or more layers wherein at least one layer is a heterogeneous mass layer, wherein the topsheet and the heterogeneous mass are integrated such that they reside in the same X-Y plane.

A composition for wound healing, comprising an amount of a macrophage proresolving polarizer, wherein the amount is effective to promote wound healing. The composition includes wherein the macrophage proresolving polarizer is lipin-1. The composition includes wherein the composition includes one, two, or three of IL-4, apoptotic cells (ACs), and AC derived lipids. The composition includes wherein the macrophage proresolving polarizer is a lipin-1 transcriptional coregulatory activity promoter. The composition includes, wherein the lipin-1 transcriptional coregulatory activity promoter is an inhibitor of lipin-1 macrophage pro-inflammatory responses enzymatic activity. A method for promoting wound healing, comprising contacting a wound on a skin of a mammal with the composition. A kit comprising one or more containers including the composition in sterile packaging. A wound healing device comprising a substrate and an amount of an amount of a macrophage proresolving polarizer, wherein the amount is effective to promote wound healing.

A portable sanitary staging assembly is utilized to place an infant or a baby on while changing a diaper, or to stage an injured person or animal, such as for triage or emergency medical treatment in the field, or for a person or animal receiving medical attention outside of a typical medical environment. A portable sanitary staging assembly includes a sanitary paper dispenser assembly having a dispenser/protector tube dimensioned to receive sanitary paper therein, the dispenser/protector tube having a dispenser slot formed through a portion of the dispenser/protector tube to facilitate dispensing the sanitary paper. A sanitary pad assembly having a main sanitary pad is interconnected to a portion of the sanitary paper dispenser assembly. A cutter mechanism is affixed to a portion of the portable sanitary staging assembly to facilitate removal and disposal of soiled sanitary paper after use.

The invention relates to a process for producing a composite material for wound dressings, comprising the following steps: (I) providing a first film, having a first film surface and a second film surface running virtually parallel to the first film surface: (II) mixing an NCO-terminated polyurethane prepolymer with at least water to give a polyurethane prepolymer/water mixture, (III) applying the polyurethane prepolymer/water mixture to at least one part of the first film surface to form a layer, the layer having a first layer surface which is in contact with the first film via at least one part of the first film surface, and having a second layer surface which runs virtually parallel to the first layer surface; (IV) covering at least one part of the second layer surface with a further film, wherein the bond strength between the first film and the layer and also between the layer and the further film is greater in each case than the tensile strain at break of the layer. The invention further relates to a composite material produced by the process of the invention and also to a wound dressing comprising such a composite material and also to the use thereof in a wound dressing for improving the absorption of wound secretion and the distribution of secretion in the wound dressing.

Flexible polyurethane (PU) material which comprises a flexible hydrophilic polyurethane foam porous matrix comprising two matrix faces and therebetween a structural matrix framework defining a network of cells, having a cell network surface and therein a network of pores and a powder charge comprising one or more additives loaded in said structural matrix framework wherein said material is a foamed polymer of a system comprising an isocyanate prepolymer or monomer phase and an aqueous phase, wherein said system comprises one or more slurry phases or solid concentrates of said powder charge, or an insoluble portion thereof, as said isocyanate phase or part thereof and/or as said aqueous phase or part thereof and/or in a carrier liquid phase; and/or comprising a powder charge of silver salt loaded in said structural matrix framework in a population of silver salt particles defined by particle size distribution about a mean particle size of greater than or equal to 1 micron, said material comprising silver salt in population of particles corresponding to silver salt comprised in powder charge pre-loading; methods for manufacture thereof, systems for control thereof, devices containing said material and methods for treatment therewith and uses thereof.

An absorbent wound dressing (1) comprising a superabsorbent material (13) that is in fluid communication with the surface of a wound to which the dressing is applied when in use. The superabsorbent material (13) is enclosed in an envelope (14,15) having a wound-facing surface that is knitted or woven from a yarn comprising gelling fibres.

A dressing for treating a wound on a digit includes a digit contact layer configured to substantially prevent adherence of the dressing to the wound and an antimicrobial layer coupled to a wound-facing side of the digit contact layer. The antimicrobial layer includes an antimicrobial substance. A first roll is coupled to a non-wound-facing side of the digit contact layer and unrollable to cover the digit, the digit contact layer, and the antimicrobial layer and a second roll is coupled to the first roll and unrollable to cover the first roll, the digit, the digit contact layer, and the antimicrobial layer.

A wound healing device and method that greatly reduces the risk of infection of an incision or wound by removing fluid from the subcutaneous skin layers. The wound healing device includes a first portion that is positioned external of, and on top of, the wound. At least one strip, cord, finger, member is in fluid communication at one end with the first portion while the second free end of the at least one strip, cord, finger, member is pushed down into the wound, in between the sutures or staples of a closed incision. Both the first portion and the at least one strip comprise fluid absorbable material for absorbing the wound fluid. The device remains in place for approximately 1-3 days after which it is removed. Upon removal, natural temporary “type of fistulae” are formed in the subcutaneous skin layers to continue draining wound fluids upward for another 1-2 days.

The present invention is directed to a hemostatic textile, comprising: a material comprising a combination of glass fibers and one or more secondary fibers selected from the group consisting of silk fibers; ceramic fibers; raw or regenerated bamboo fibers; cotton fibers; rayon fibers; linen fibers; ramie fibers; jute fibers; sisal fibers; flax fibers; soybean fibers; corn fibers; hemp fibers; lyocel fibers; wool; lactide and/or glycolide polymers; lactide/glycolide copolymers; silicate fibers; polyimide fibers; feldspar fibers; zeolite fibers, zeolite-containing fibers, acetate fibers; and combinations thereof; the hemostatic textile capable of activating hemostatic systems in the body when applied to a wound. Additional cofactors such as thrombin and hemostatic agents such as RL platelets, RL blood cells; fibrin, fibrinogen, and combinations thereof may also be incorporated into the textile. The invention is also directed to methods of producing the textile, and methods of using the textile to stop bleeding.